Synthes guilty in S&N (Smith & Nephew) patent case:
This article was originally published in Clinica
Executive Summary
Smith & Nephew (S&N) has won a patent infringement dispute concerning two intramedullary nail products sold by rival Synthes. A US district court ruled that Synthes' trochanteric fixation nail and proximal femoral nail products did infringe two patents owned by S&N, and upheld the validity of these patents. Remedies for this infringement have yet to be determined by the court. Intramedullary nails are placed inside the bone to help healing of bone fractures.
You may also be interested in...
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.